RECENT NEWS

The Global Virus Network (GVN) marked the opening of its International Headquarters on 5 March at the University of South Florida (USF) Institute for Translational Virology and Innovation (ITVI), a GVN Center of Excellence.

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

The House of Lords Science and Technology Committee has launched an inquiry into innovation in the NHS, with a focus on personalised medicine and AI.

New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published studies

Agilent Technologies has announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million.

Eppendorf has announced the commercial launch of the SpinPro 6 R centrifuge, the first in the new range of SpinPro floor-standing and benchtop centrifuges.

Scientists at Duke-NUS Medical School have found that viruses circulating in live poultry markets can be detected more effectively by sampling the surrounding environment than by testing individual birds.

A new international research effort is underway to find the best ways to protect babies from respiratory syncytial virus (RSV), a common infection of the nose, throat and lungs that can cause serious breathing problems in young children.

AI pathology firm PathAI has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to PathAssist Derm, designed to analyse digital pathology whole slide images (WSIs) of skin lesions and aid pathologists in their review.

Leica Biosystems streamlines multiplex immunofluorescence (IF) for oncology and translational research with the launch of its BOND 4-Plex Fluorescent Detection Kit for research use only.

Rapid testing for bacterial infections is being rolled out in community pharmacies and GP surgeries across Wales.

Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, have announced a three-year collaboration aimed at better understanding why inflammatory bowel disease (IBD) runs in some Saudi families, and how that knowledge can lead to risk ascertainment, earlier diagnosis and more personalised treatment options.

Coronaviruses not only use the machinery of the human cells they infect; they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly.

AI-powered digital diagnostics company Techcyte has announced that its Fusion AP platform has achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR).

Thermo Fisher Scientific has introduced the Fluid Ease Pro ClipTip electronic pipette which includes the first large, high-resolution pipette touchscreen on the market, as well as intelligent power management and advanced programming capabilities.

A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports.

DNA sequencing and array-based technology firm Illumina has unveiled a suite of advancements that will accelerate the next era of genomic discovery.

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

Point-of-care diagnostic firm BHR Biosynex has appointed Adam Martin as Country Manager for the UK and Ireland.

Epredia and Mindpeak have announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.